The Fulham Shore Share Discussion Threads

[scruff1] 19/6/2009 18:40

60% spread. This must be close to being a flat liner.

[platts] 10/6/2009 22:25

I dont think the new ceo is anything to write home about

[bbd2] 08/6/2009 11:52

New management - new broom now can we please have a new share price !!

[yogro] 08/6/2009 02:55

the rocket ship fulcrum

[gimeabreak] 24/5/2009 23:10

I wonder why I didn't realise just how manipulated this share is so much so its impossible make any money either buying or selling the spreads prevent that
Just got to hold and hope this company succeeds in a big way, I wonder what the chances of that.Does anybody remember that Fulcrum was involved in the formulation of a synthetic drug for Malaria was wondering how that was going especially as there is some evidence that the parasite is supposedly becoming resistant to modern drugs Now that would be a bagger ;-}

[velvetide] 20/5/2009 14:51

saw this on the top losers, sorry for holders

was a shareholder for some 5 years until first thing in the morning after the results last week,

reasons:

(1) somewhat of a lacklustre set of results compared to promises over the years
(2) this stock always spikes on results

but most importantly

(3) its a SEAQ stock, I am just selling stocks which have prices dictated pretty much only by the mm's, imo whosever interests they are acting in, that group has never included me.

Oil SEAQ stocks appear different but all others I'm out of.



imo, to anyone looking to invest in smaller stocks, check out some SETSmm quoted ones, much more fun like investing should be

[platts] 20/5/2009 10:12

back to 2.25p any takers?

[mountain man] 19/5/2009 14:27

ansc
I agree with all you've said - exactly why I shall hold mine and increase my holding when possible. A growing head-count tells me that business is moving in the right direction - no company is taking on staff without good reason in this financial climate.
Traders will find this share disappointing but IMHO long term investors will be rewarded. We shall see - only time will tell.

[platts] 19/5/2009 14:22

you can get it for 2.5p my guess is that if you placed a large order the stock would spike up. how much volume does this company actually turn over per month?

[ansc] 19/5/2009 12:43

It's worth bearing in mind that over the past couple of years, numerous directors' purchases have been made at a price of 3.5p or slightly above. If they were confident enough to buy at that kind of price, and the company having grown in the meantime, surely a price c. 2.75p or below should appear quite appealing. A 'director buy' RNS would undoubtedly move the share price north pronto.

[platts] 19/5/2009 10:57

ansc: I agree with your points. unfortunately the stock is currently too low in price for any of the funds to purchase, however optimistic the company is about itself. of course in the long run ful may present itself as quite cheap, however in the long run we are all going to die as well.

[ansc] 19/5/2009 10:12

It never ceases to surprise me when investors seem to judge a company solely by it's (historical) bottom-line profit figure, as is clearly happening with FUL since their Interim announcement last week.

Yes, on the surface, disappointing figures but there are plenty of pointers in the report to warrant holding for better times:
* Cash of £2.7m (even after paying-off £0.46m);
* Pharma and biotechnology companies have understandably slowed in investing during this economic downturn but, sooner or later, they will need to commit simply to stay in business and the trend towards outsourcing is apparently continuing to grow;
* Head count has again increased - to 152 at half-year end - hardly an indication of a company struggling to keep their head above water;
* Although revenue in the EU and PDC was down 10%, the business restructuring programme already implemented should increase efficiency in the second half of 2009 and beyond;
* Real-time revenue in the US up 9% and office expansion continues apace;
* Japanese real-time revenue up 13% and again business opportunities expanding.

The chairman was not exactly downhearted either in his closing comments:
"Future strategy and outlook
The Board and Management of Fulcrum Pharma remain convinced of the opportunity
that exists to substantially grow the business through winning bigger PDC
projects and building a substantial regulatory business, and these two limbs of
the business strategy are progressing satisfactorily. The harsh market
conditions, particularly since the beginning of the year, have impacted Fulcrum
Pharma in H1 2009, though the Group has increased revenues and maintained a
strong cash position. Fulcrum Pharma continues to be very active in business
development with clients and has generated a substantial number of new
proposals. In addition, the actions being taken to reduce the cost base should
lead to an overall stronger Fulcrum Pharma business."

[mountain man] 18/5/2009 16:26

platts
Patience is required - the market will pick this up eventually but it may be at least another 12 months away yet. It's the next two full year results I will be interested in.
I think one has to judge performance against the recession - I've been through four so I understand how tough it is out there. I've no doubt FUL will emerge stronger at the end of this one.

[platts] 18/5/2009 15:46

as predicted- after its little advance- the stock is now falling back- just no traction for this unloved company!

[gimeabreak] 16/5/2009 15:27

When one views so many other companies results you realise just how well Fulcrum has performed.So credit to them!In fact I think I'll hold for another seven years and possibly make a bob or three profit.Well done Fulcrum!!

[platts] 14/5/2009 10:52

any comment about the feeble final profit? I think the financial management is laughable actually. still the stock has risen- for how long though?

[mountain man] 14/5/2009 09:55

ansc

Agreed - very satisfactory results for the half year and I'm content to hold. We may see a bolt-on acquisition - with plenty of cash now is the time to take advantage in these difficult times.

[ansc] 14/5/2009 08:19

A complex Interim statement but (imho) the company still appears to be heading in the right direction. The MMs, having successfully subdued potential investors in the run-up to the announcement with their massive spread, predictably hoick the share price North before a single trade has been executed!

[addict] 11/5/2009 13:46

ansc,
My recent buys were priced as sells.There's something going on here methinks.MM's are looking for stock.The growth of late has been impressive and the business is cash generative.My money's on good results plus some corporate activity.DYOR

[ansc] 11/5/2009 12:48

During the five years I've held FUL, this is the first time it's ever been possible to get a firm quote online to sell 150k of shares albeit for only 2.30p each. A buy quote, however, is limited to a mere 5k at a price of 2.95p.

It could be an interesting run up to Thursday ......

[addict] 11/5/2009 10:01

Mountain man,
Market makers having a laugh with this share-50% spread.Interesting that any volume buying is at full price.Patience will be rewarded here.DYOR

[mountain man] 08/5/2009 21:08

addict

I've held for several years and added a couple of months ago. Like ansc, I am looking forward to the results this time round and expecting FUL to show real progress.
I didn't know results were due next week?

[addict] 08/5/2009 15:49

Yes,DAPATRIOT-those in WILL be laughing.DYOR